MISTIE INTRACEREBRAL HEMORRHAGE TRIAL

Does faster clot removal give better patient outcomes in ICH?

110 Sites to Quality:
50
90 Sites to Activate:
41
500 Participants to Enroll:
39
  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
  • Bloggers
    Bloggers Search for your favorite blogger from this site.
  • Archives
    Archives Contains a list of blog posts that were created previously.
  • Login
    Login Login form

MISTIE

518

The 12th Annual Neurocritical Care Society (NCS) Meeting will be held this year in Seattle on 11-14 September. There will be a comprehensive session on intracerebral hemorrhage, including reviews of exciting recent advances in the translational, epidemiological and clinical areas. 

Friday’s focus on ICH will provide cutting-edge science, clarity in the practice of complex clinical problems, and maybe even stir up a little controversy. Our MISTIE/CLEAR Lead Investigator, Dr. Daniel F. Hanley, will be speaking as well, on interventional treatment so you don't want to miss it. Click here for details.

142

In collaboration with the Johns Hopkins University School of Medicine Office of Continuing Medical Education, we now provide continuing medical education (CME) credits, specifically AMA PRA Category 1 Credit™, for completing the online MISTIE-III investigator training courses.   You may earn up to 9 hours, but you must take a specific set of courses. You must also be a registered user of this site.

672

We are delighted to report that the first patient has now enrolled in the MISTIE III intracerebral hemorrhage trial! In the race to be the first out-of-the-gate, the honor goes to Hartford Hospital.

Dr. Inam Kureshi and his team at Hartford enrolled patient #1 at 17:02 on 30-Dec-2013, marking the official start of the study period. Congratulations go out to the Hartford team which includes the coordinator, Sara Jasak, RN, and the neurointensivist, Dr. Robert Brown. This was the 12th patient to be screened at this site since the site was activated on 11-December. We are especially proud of how Sara Jasak has entered the clinical data in near real-time; just a few days into the acute treatment and we already have 54 final case form pages with no open queries! Way to go, Sara!

Continue reading
667

It's almost time to start screening and enrolling patients in MISTIE III! The Reading Center has put together some instructions for uploading images to the Vision EDC directly from your PACS system. Click "read more" to view the instructions and download the files for a quick reference. 

Continue reading
624

b2ap3_thumbnail_outcomes.jpg

Our monthly webinars in December and January will focus on outcomes testing in MISTIE III. This is a critically important topic, as the MISTIE trial is designed to determine if the MISTIE procedure improves long term functional outcomes. Therefore, we need all of you to become outcome assessment experts!

Please invite anyone from your site who will be performing outcome assessments to attend both webinars: 

Tuesday, December at 8am or 2pm EST

Tuesday, January 7 at 8am or 2pm EST

If you are not already registered to attend the MISTIE webinars, you can sign up here: 

8am session https://www2.gotomeeting.com/register/428431762 

2pm session https://www2.gotomeeting.com/register/271675626

Continue reading

Brain Injury Outcomes

Johns Hopkins University
1550 Orleans Street
CRB-II, 3M50 South
Baltimore, MD 21231 USA
Office:   (410) 614-6996
Fax: (410) 502-7869
 
24-Hr: (410) 736-1368

Site Locations

Click marker for details. Green = active; yellow = planned. Location of sites in Australia, China, Singapore and Mongolia not yet determined.